Vishakha A. Kale

Hematology
12901 Bruce B Downs Blvd
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy.

Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy.

Journal: Leukemia research
Published: August 28, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026